| 摘要 |
<p>The present invention relates to novel Silyl-Containing Heterocyclic Compounds of Formula (I): and pharmaceutically acceptable salts thereof, wherein A, B, C, D, E, F and L are as defined herein. The present invention also relates to compositions comprising at least one Silyl-Containing Heterocyclic Compound, and methods of using the Silyl-Containing Heterocyclic Compounds for treating or preventing HCV infection in a patient.</p> |
| 申请人 |
MERCK SHARP & DOHME CORP. |
发明人 |
DWYER, MICHAEL, P.;KEERTIKAR, KARTIK, M.;ZENG, QINGBEI;MAZZOLA, ROBERT, D., JR.;YU, WENSHENG;TANG, HAIQUN;KIM, SEONG HEON;TONG, LING;ROSENBLUM, STUART, B.;KOZLOWSKI, JOSEPH, A.;NAIR, ANILKUMAR GOPINADHAN |
